In March 2024 the FDA approved semaglutide to help to lower the risk of cardiovascular death, heart attack and stroke in overweight or obese patients (Patchen)
We offer a range of pea protein isolates that are non-GMO, allergen-free, and all-natural ingredients
doi:10.1007/s12020-024-03998-8 Finan B, Ma T, Ottaway N, et al
Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA Compounded Semaglutide (GLP-1) Injections A once-weekly GLP-1 injection designed to help reduce appetite, improve metabolic health, and support sustainable weight loss under licensed medical supervision
Often, these outlets will claim to produce personalized GLP-1s combined with vitamins like B12 or other ingredients, some even marketing them as improved versions
Significance is indicated with asterisks * and a minimum P value of 0.05 was considered statistically significant (refer to figure legends for details)